Isotonix Essentials舒壓助眠沖飲 - 單盒裝(30包)

$69.95 USD

生活難免時時感到失衡與挫敗,特別是心情低落時突然來襲的煩躁與憂慮情緒。有時候您只需要將自己暫時從忙碌的生活壓力與繁瑣的思緒中解脫出來,享受片刻安寧。Isotonix Essentials™系列產品為您的生活找回些許平靜。Isotonix Essentials™舒壓助眠沖飲專為放鬆精神而設,含有特殊配製的多種維生素、胺基酸與礦物質等成分,並採用便於使用的單包包裝。配方中所含的主要成分有助於安撫身體,促進思緒清晰,舒緩精神緊張,並且改善睡眠品質。將生活節奏放慢些,許多人都會從中受益。根據美國壓力管理學院(American Institute of Stress)統計,因為壓力,77%的人經常感到身體不適(例如:疲勞、頭痛、肌肉緊繃);76%的人經常遇到心理問題(例如:易怒、缺乏活力、感到緊張);而48%的人因此導致夜間失眠。值得注意的是,形成壓力的主要原因有工作壓力、金錢、健康、人際關係、營養不良、媒體資訊超載以及睡眠剝奪。*上述文字未經美國食品藥物管理局評估。本產品無意作為診斷、治療或預防任何疾病之用。

此產品符合減免運費。

產品詳細資料

Isotonix Essentials™ Turn Down舒壓助眠沖飲的主要好處

Isotonix Essentials™ Turn Down舒壓助眠沖飲的主要好處
  • 有助改善並穩定情緒
  • 可促進平靜與放鬆
  • 支援健康的睡眠品質
  • 促進睡眠
  • 協助釋放精神緊張
  • 有助頭腦清晰
  • 幫助正常的酵素調節與荷爾蒙分泌
  • 促進認知健康
  • 提供抗氧化保護
  • 不含麩質、小麥、黃豆、酵母、人工調味、鹽、防腐劑或奶類

Why Choose Isotonix Essentials™ Turn Down?

It’s hard to feel balanced and grounded sometimes, especially when restless and worrying thoughts cut into your downtime. Sometimes you just need to free yourself from life’s to-do lists and halt the brakes on your ruminating mind. Bring some calmness into your life with
Isotonix Essentials™.

Designed for relaxation, Isotonix Essentials™ Turn Down features a custom blend of vitamins, amino acids and minerals all in one easy-to-use packet. The formula contains effective key ingredients to help you quiet down your body, promote mental clarity, control mental tension and support healthy sleep quality. 

Many people can benefit from slowing down life a little. According to the American Institute of Stress, 77% of people regularly experience physical symptoms caused by stress (e.g. fatigue, headache, muscle tension); 76% regularly experience psychological symptoms caused by stress (e.g. irrihttps://www.stress.org/daily-life)

*These statements have not been evaluated by the Food and Drug Administration. This product(s) is not intended to diagnose, treat, cure or prevent any disease.

FAQ

What does Isotonix® mean?
Isotonix® dietary supplements are delivered in an isotonic liquid solution. This means that the body has less work to do in obtaining maximum absorption. The isotonic state of the suspension allows nutrients to pass efficiently into the small intestine and be rapidly delivered into the bloodstream. With Isotonix® products, little nutritive value is lost, making the absorption of nutrients highly efficient while delivering maximum results.*

Who should use this product?
Anyone looking for rest and relaxation support, and those looking for solutions support sleep quality affected by everyday stressors (e.g. travel, occupation, family).*

How do I take Isotonix Essentials™ Turn Down?
Pour contents of packet into a cup. Add 8 fl. oz of water into the cup and stir. Maximum absorption occurs when taken on an empty stomach.

How often should I use Isotonix Essentials™ Turn Down?
As a dietary supplement, take once daily or as directed by your healthcare provider. 

When should I take Isotonix Essentials™ Turn Down?
Take this product when you are looking for moments of stress relief and relaxation.

How is Isotonix Essentials™ Turn Down different from other similar products on the market?
Isotonix Essentials™ Turn Down knows you need the building blocks to feel refreshed, and that is why we offer a blend of minerals and amino acids that support rest and relaxation.*

Are there any contraindications or warnings for this product?
If you are currently using any prescription drugs, have an ongoing medical condition or are pregnant or breastfeeding, you should consult your healthcare provider before using this product.
 
*These statements have not been evaluated by the Food and Drug Administration. This product(s) is not intended to diagnose, treat, cure or prevent any disease.

Isotonix Essentials™ Turn Down舒壓助眠沖飲的主要成分

左旋色胺酸:500毫克

在人體內,色胺酸會被轉換為5-羥色胺酸,進而再被轉換為血清素。人體無法自然生成色胺酸,因此必須透過飲食或補充品攝入。色胺酸是眾多動、植物蛋白的組成部分。色胺酸的食物來源包括乳製品、牛肉、家禽、大麥、糙米、魚、大豆和花生。*

 

維生素C(抗壞血酸):604毫克

維生素C存在於椒類(甜椒、青椒、紅椒、紅辣椒及青辣椒)、柑橘類水果、結球甘藍、白花菜、高麗菜、羽衣甘藍菜、芥蘭菜、芥菜、綠花椰菜、菠菜、番石榴、奇異果、黑醋栗及草莓。堅果類及穀類亦含有微量的維生素C。維生素C的活性營養價值很容易因烹煮而受損。

維生素C維護健全的免疫系統,促進心血管健康,維持正常的膽固醇值,並且提供抗氧功能。人體無法自行製造及儲存維生素C。維生素C僅能透過飲食和攝取營養補充品而取得。* 

 

鉀(碳酸氫鉀):384毫克

鉀儲存於肌肉內。富含鉀的食物包括香蕉、柳橙、哈蜜瓜、酪梨、生菠菜、甘藍菜和芹菜。鉀是必要的巨量礦物質,能幫助維持體液平衡。鉀同時促進各種生化和生理過程。鉀有助維持正常的神經脈衝傳遞,心臟、骨骼肌及平滑肌的收縮,合成核酸,維持細胞內張力以及正常的血壓。在1928年,首次有人提出攝取大量的鉀可以幫助維持心血管健康。鉀有助正常的肌肉放鬆以及胰島素分泌。同時還可促進肝糖和蛋白質的合成。鉀是促進正常心跳的電解質。鉀支援人體調節水平衡的能力、運動後的恢復及人體廢物之排除。*

鈣(乳酸鈣、碳酸鈣、硫酸鈣、檸檬酸鈣):375毫克

牛奶含有食物中最高濃度的鈣質。其他富含鈣質的食物包括豆腐及羽衣甘藍、大白菜、芥菜、綠花椰菜、青江菜等蔬菜。鈣質是重要的礦物質,具有多項生化功能。鈣質主要是以氫氧基磷灰石的形式(Ca10 (PO4)6 (OH) 2)存在於骨骼之中。

羥磷灰石約佔骨骼整體重量的40%。骨骼發育需要補充鈣質,而且骨骼也是鈣質的儲藏室。鈣質除了是骨骼與牙齒的主要成分外,也能支援正常的肌肉收縮、神經健康、心跳規律、血液凝結、腺體分泌、能量生成及免疫系統功能。*

每天補充足量的鈣質,對於維持骨骼密度及健康的骨骼與牙齒是必要的,經證實也可緩解女性經前症候群的不適。若沒有每日攝取足夠的鈣質,身體會從骨骼中吸取鈣質,進而造成骨質流失。

血液中鈣質的含量是由PTH(副甲狀腺荷爾蒙)調節。攝取高劑量的鈣質可維護正常的心血管健康,並維持正常的膽固醇指數。美國糖尿病協會期刊(American Dietetic Association Journal)的研究指出,鈣有助中年婦女維持健康的體重。

鎂(碳酸鎂、檸檬酸鎂、甘胺酸鎂、氧化鎂):300毫克

鎂是骨骼礦化的元素之一,促進成人體內鉀和鈣的正常代謝。鎂有助維持體內鉀、磷、鈣、腎上腺素及胰島素的正常含量。鎂也能促進鈣的正常移動,將它運送到細胞內進一步利用。鎂在肌肉和神經組織的正常運作上也扮演重要的角色。鎂同時有助於合成所有的蛋白質、核酸、核苷酸、環磷酸腺苷、血脂以及碳水化合物。

鎂可與鈣一同作用,維護正常的心臟功能及血壓。鎂同時也是健康的骨骼和牙齒所不可或缺,並有助健康的肌肉發育。鎂、鈣及維生素D三者共同維持骨骼健康。鎂協助維持正常的血小板活動,因此有助促進健康的心血管功能,以及維持正常的膽固醇指數。*

菸鹼酸(菸鹼醯胺):20菸鹼素總量毫克

菸鹼酸是200種酵素的輔酵素(NAPH/ NADPH),對於促進正常的組織呼吸、脂肪酸與類固醇荷爾蒙的合成、碳水化合物與胺基酸的代謝、以及氫氣的傳輸都是必要的。菸鹼酸濃度過低時,身體可以利用左旋色胺酸製造。身體需60毫克的左旋色胺酸才能產生1毫克的菸鹼酸,這個過程會快速減少左旋色胺酸含量。當體內有足夠的菸鹼酸時,左旋色胺酸便可用在其他地方,例如維持健康的血清素濃度。*

 

維生素B6(鹽酸吡哆醇):4毫克

維生素B6促進正常的神經脈衝傳導,類固醇荷爾蒙調節,葡萄糖的肝醣分解,原血紅素合成,以及胺基酸與神經傳導物質的合成/代謝。維生素B6在轉換為磷酸吡哆醛(PLP)之後,可作為許多酵素反應的輔因子,參與左旋色胺酸活動,包括將左旋色胺酸轉換為血清素。*

核黃素(維生素B2):2.9毫克

維生素B2存在於肝臟、乳製品、深綠色蔬菜和某些種類的海鮮。維生素B2是一種輔酵素,和其他的維生素B協同作用。維生素B2可以增進健康的紅血球生成、維持神經系統、呼吸作用、抗體生成,與人類正常的生長。維生素B2支持健康的皮膚、指甲,與頭髮生長並促進正常的甲狀腺活動(健康的甲狀腺對於健康的體重等狀態的維持是必須的)。維生素B2支援身體將食物轉換為能量的能力,是電子傳遞鏈的一部分,能給予細胞能量。核黃素對孕婦與哺乳中的婦女相當有用,熱量需求高的運動員也相當需要。維生素也可促進正常的脂肪分解。維生素B2為水溶性,除非攝取相當大的分量,否則無法儲存於人體內,必須每天補充。*

錳(硫酸錳):5毫克

錳是一種在植物和動物裡都可大量發現的礦物質。錳最重要的飲食來源包含全穀類、堅果、葉菜和茶。錳大量存在於穀糠,但穀糠常在加工過程中去除。

人體組織內僅含有微量的錳。錳主要儲存於骨骼、肝臟、腎臟和胰腺。錳有助維護結締組織、骨骼、凝血因子以及性荷爾蒙的正常功能。它同時促進正常的脂肪和碳水化合物的代謝,幫助鈣質吸收,並維持血糖正常。錳亦有助維護正常的大腦及神經功能。

錳是抗氧化酵素-錳超氧化物歧化酶(MnSOD)-的組成部分。抗氧化物可清除人體內天然產生的自由基,但此過程可能造成老化。如錳超氧化物歧化酶(MnSOD)的抗氧化物能夠中和自由基。

專家估計,37%的美國人並未從他們的日常飲食中攝足建議的每日錳攝取量,這可能是因為許多美國人食用精製的穀類食物多於全穀類食物,而全穀類食物卻是錳主要的膳食來源。相較於全穀類食物,精製的穀類食物只能提供一半份量的錳。*


 

硼(檸檬酸硼):5毫克

礦物質硼主要來源為植物性食物如水果乾、堅果、深綠色葉菜、蘋果泥、葡萄汁及烹煮過的乾豆類。硼存在於大部分的身體組織中,但主要分布在骨骼、脾臟與甲狀腺。硼支援正常的骨骼與荷爾蒙代謝。硼支援身體的建構能力,維持健康的骨骼。也可幫助留住足夠的鈣與鎂,促進適當的骨骼礦化。硼是將維生素D轉化成活性成分的必要輔因子。有助維持健康的細胞膜、支援適當的心智功能與警覺性、以及維持血清中正常的雌激素與游離鈣濃度。*

維生素 D3(膽鈣化醇):12.5微克(500國際單位)

大多數人類獲得維生素D的主要途徑是規律的日曬。維生素D的飲食來源包括維生素D強化牛奶(每杯含100國際單位)、鱈魚肝油及富含脂肪的魚類(例如鮭魚),也少量存在於蛋黃與肝臟中。*

維生素D可以幫助鈣和磷的吸收,它還協助製造數種有助於鈣質吸收和儲存的蛋白質。維生素D與鈣兩者共同促進骨骼強壯。維生素D有助將造骨細胞中的鈣質運送至細胞外液和腎臟,也可促進腎小管與腸上皮對鈣與磷的再吸收。維生素D亦支援皮膚細胞的正常生長,有助維持胰腺正常分泌胰島素。*

維生素A1%β-胡蘿蔔素):362微克視黃醇活性當量

維生素A是脂溶性維生素。維生素A的來源包括動物內臟(如肝臟和腎臟)、蛋黃、奶油、紅蘿蔔汁、南瓜、番薯、菠菜、桃子、強化乳製品和鱈魚肝油。維生素A是視黃醇、視黃醛和β-胡蘿蔔素等複合物家族的成員。維生素A提供全身組織的正常發育及修護。*

Science

  • aan het Rot, M., et al. Social behaviour and mood in everyday life: the effects of tryptophan in quarrelsome individuals. Journal of Psychiatry and Neuroscience. 31(4): 253-262, 2006.
  • Allender PS, Cutler JA, Follman D, et al. Dietary calcium and blood pressure: meta—analysis of randomized clinical trials. Ann Intern Med. 1996; 124:825-831. 
  • Altura BM and Altura BT. Magnesium and cardiovascular biology: An important link between cardiovascular risk factors and atherogenesis. Cell Mol Biol Res. 41:347-59, 1995.
  • Altura BM, Altura BT. Role of magnesium and calcium in alcohol-induced hypertension and strokes as probed by in vivo television microscopy, digital image microscopy, optical spectroscopy, 31P-NMR, spectroscopy and a unique magnesium ion-selective electrode. Alcohol Clin Exp Res. 1994; 18:1057-1068. 
  • Appel LJ. Nonpharmacologic therapies that reduce blood pressure: A fresh perspective. Clin Cardiol. 22:1111-5, 1999.
  • Baly DL, Schneiderman JS, Garcia-Welsh AL. Effect of manganese deficiency on insulin binding, glucose transport and metabolism in rat adipocytes. J Nutr. 1990; 120:1075-1079. 
  • Barker J. Insomnia options; natural medicine choices. Townsend Letter for Doctors and Patients. April 2004.
  • Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. N Engl J Med 1999;340:101-107. 
  • Baron JA, Tosteson TD, Wargovich MJ, et al. Calcium supplementation and rectal mucosal proliferation: a randomized controlled trial. J Natl Cancer Inst 1995;87:1303-1307. 
  • Baxter GF, Sumeray MS, Walker JM. Infant size and magnesium: insights into LIMIT-2 and ISIS-4 from experimental studies. Lancet. 1996; 348:1424-1426. 
  • Beattie JH, Peace HS. The influence of a low-boron diet and boron supplementation on bone, major mineral and sex steroid metabolism in postmenopausal women. Br J Nutr. 1993 May;69(3):871-84. 
  • Bell , C., et al. Tryptophan depletion and its implications for psychiatry. British Journal of Psychiatry. 178: 399-405, 2001.
  • Bell L, Halstenson CE, Halstenson CJ, et al. Cholesterol-lowering effects of calcium carbonate in patients with mild to moderate hypercholesterolemia. Arch Intern Med. 1992; 152:2441-2444.
  • Bilbey, D.L. J., et al. Muscle cramps and magnesium deficiency: case reports. Can Fam Physician. 42:1348-51, 1996.
  • Booij, L., et al. Acute tryptophan depletion as a model of depressive relapse. British Journal of Psychiatry. 187: 148-154, 2005.
  • Bostick RM, Kushi LH, Wu Y, et al. Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol 1999;149:151-160. 
  • Brilla, L. R., et al. Effect of magnesium supplementation on strength training in humans. J Am Coll Nutr. 11(3):326-329, 1992.
  • Britton J, Pavord I, Richards K, et al. Dietary magnesium, lung function, wheezing, and airway hyper-reactivity in a random adult population sample. Lancet. 1994; 344:357-362. 
  • Brown R. and Gerbarg P. Herbs and nutrients in the treatment of depression, anxiety, insomnia, migraine, and obesity. J Psychiatr Pract. 7(2):75-91, 2001.
  • Buckley LM, Leib ES, Cartularo KS, et al. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. Ann Intern Med. 1996; 125:961-968. 
  • Caddell JL. Magnesium deficiency promotes muscle weakness, contributing to the risk of sudden infant death (SIDS) in infants sleeping prone. Magnes Res. 14(1-2):39-50, 2001. Review.
  • Casscells W. Magnesium and myocardial infarction. Lancet. 1994; 343:807-809. 
  • Chollet D et al. Blood and brain magnesium in inbred mice and their correlation with sleep quality. Am J Physiol Regul Integr Comp Physiol. 279(6):R2173-8, 2000.
  • Christiansen CW, Rieder MA, Silverstein EL, Gencheff NE. Magnesium sulfate reduces myocardial infarct size when administered before but not after coronary reperfusion in a canine model. Circulation. 1995; 92:2617-2621. 
  • Christin Marandino, Vegetarian Times, August 1998 Curhan GC, Willett WC, Speizer FE, et al. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk of kidney stones in women. Ann Intern Med. 1997; 126:497-504. 
  • Cools, R., et al. Tryptophan depletion disrupts the motivational guidance of goal-directed behavior as a function of trait impulsivity. Neuropsychopharmacology. 30:1362-1373, 2005.
  • Corsonello A et al. Serum magnesium levels and cognitive impairment in hospitalized hypertensive patients. Magnes Res. 14(4):273-82, 2001.
  • Dahle, L. O., et al. The effect of oral magnesium substitution on pregnancy-induced leg cramps. Am J Obstet Gynecol. 173(1):175-180, 1995.
  • Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density on men and women 65 years of age and older. N Engl J Med. 1997; 337:670-676. 
  • de Lourdes Lima M, Cruz T, Carreiro Pousada J, et al. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care. 1998; 21:682-686. 
  • Del-Ben, C., et al. Serotonergic modulation of face-emotion recognition. Brazilian Journal of Medical and Biological Research. 41(4): 263-269, 2008.
  • Demirkaya S et al. A comparative study of magnesium, flunarizine and amitriptyline in the prophylaxis of migraine. J Headache Pain. 1:179-86, 2000.
  • Dietary Reference Intakes for Calcium, Phosphorous, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academy Press; 1997. 
  • Durlach J, Durlach V, Bac P, et al. Magnesium and therapeutics. Magnes Res. 1994; 7:313-328. 
  • Elisaf M, Merkouropoulos M, Tsianos EV. Siamopoulos KC. Pathogenetic mechanisms of hypomagnesemia in alcoholic patients. J Trace Elem Med Biol. 1995; 9:210-214. 
  • Elisaf M, Milionis H, Siamopoulos K. Hypomagnesemic hypokalemia and hypocalcemia: Clinical and laboratory characteristics. Mineral Electrolyte Metab. 23:105-12, 1997.
  • Facchinetti F, Borella P, Sances G, et al. Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol. 1991; 78:177-181. 
  • Garland CF, Garland FC, Gorham ED. Calcium and vitamin D. Their potential roles in colon and breast cancer prevention. Ann NY Acad Sci. 1999; 889:107-119. 
  • Gong H, Amemiya T. Optic nerve changes in manganese-deficient rats. Exp Eye Res. 1999; 68:313-320. 
  • Griffiths , W., et al. Tryptophan and sleep in young adults. Psychophysiology. 9(3): 345-356, 1972.
  • Gruber H et al. Magnesium deficiency: effect on bone mineral density in the mouse appendicular skeleton. BMC Musculoskelet Disord. 4(1):7, 2003.
  • Gullestad L, Dolva LO, Soyland E, et al. Oral magnesium supplementation improves metabolic variables and muscle strength in alcoholics. Alcohol Clin Exp Res. 1992; 16:986-990. 
  • Guran T et al. Cognitive and psychosocial development in children with familial hypomagnesaemia. Magnes Res. 24(1):7-12, 2011.
  • Hartmann, E. and Spinweber, C. Sleep induced by L-tryptophan. Effect of dosages within the normal dietary intake. The Journal of Nervous and Mental Disease. 167(8): 497-499, 1979.
  • Health & Medicine. (Statistical Data Included) American Fitness, July, 1999 Tannen RL. Effects of potassium on blood pressure control. Ann Intern Med. 1983; 98(part 2):773-780. 
  • Heaney RP. Calcium, dairy products and osteoporosis. J Am Coll Nutr. 2000; 19(2 Suppl):83S-99S. 
  • Hornyak M et al. Magnesium therapy for periodic leg movements-related insomnia and restless legs syndrome: an open pilot study. Sleep. 21:501-5, 1998.
  • Houston M. The role of magnesium in hypertension and cardiovascular disease. J Clin Hypertens (Greenwich). 13(11):843-7, 2011. Review.
  • Huerta MG, Roemmich JN, Kington ML, et al. Magnesium deficiency is associated with insulin resistance in obese children. Diabetes Care. 28:1175-81, 2005.
  • Huskisson E et al. The influence of micronutrients on cognitive function and performance. J Int Med Res. 35(1):1-19, 2007. Review.
  • Hussain S, Ali SF. Manganese scavenges superoxide and hydroxyl radicals: an in vitro study in rats. Neuroscience Letters. 1999; 261:21-24. 
  • Inna Slutsky et al. Enhancement of Learning and Memory by Elevating Brain Magnesium. Neuron. 65(2):165-77, 2010.
  • Institute of Medicine. Food and Nutrition Board. Dietary Reference Intakes: Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride. National Academy Press. Washington, DC, 1999.
  • ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulfate in 58,050 patients with suspected acute myocardial infarction. Lancet. 1995; 345:669-685. 
  • Jee SH et al. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens. 15:691-6, 2002.
  • Jorde R, Sundsfjord J, Haug E, et al. Relation between low calcium intake, parathyroid hormone, and blood pressure. Hypertension 2000;35:1154-1159. 
  • Kao WHL, Folsom AR, Nieto J, et al. Serum and dietary magnesium and the risk for type 2 diabetes mellitus (editorial). Arch. Int Med. 1999; 159:2151-2159. 
  • Keen CL, Ensunsa JL, Watson MH, et al. Nutritional aspects of manganese from experimental studies. Neurotoxicol. 1999; 20:213-223. 
  • Khosh, F. Natural approach to hypertension. Alternative Medicine Review. 6(6), 2001.
  • Kobrin SM and Goldfarb S. Magnesium Deficiency. Semin Nephrol. 10:525-35, 1990.
  • Krieger D, Krieger S, Jansen O, et al. Manganese and chronic hepatic encephalopathy. Lancet. 1995; 346:270-274. 
  • LeMarquand, D., et al. Behavioral disinhibition induced by tryptophan depletion in nonalcoholic young men with multigenerational family histories of paternal alcoholism. American Journal of Psychiatry. 156: 1771-1779, 1999.
  • Lim R, Herzog WR. Magnesium for cardiac patients: is it a valuable treatment supplement? Contemp Int Med. 1998; 10:6-9. 
  • Lipkin M, Newmark H. Effect of added dietary calcium on colonic epithelial-cell proliferation in subjects at high risk for familial colonic cancer. N Engl J Med. 1985; 313:1381-1384. 
  • Lopez-Ridaura R et al. Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care. 27:134-40, 2004.
  • Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med. 1995; 333:201-205. 
  • Maizels, M., et al. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache. 44(9):885-90, 2004.
  • Martini LA. Magnesium supplementation and bone turnover. Nutr Rev. 1999; 57:227-229. 
  • Mauskop A, Altura BM. Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci. 1998; 5:24-27. 
  • Mauskop, A., et al. Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci. 5(1):24-27, 1998.
  • Meyer KA et al. Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am J Clin Nutr. 71:921-30, 2000.
  • Monograph. L-Tryptophan. Alternative Medicine Review. 11(1): 52-56, 2006.
  • Murphy, S., et al. Tryptophan supplementation induces a positive bias in the processing of emotional material in healthy female volunteers. Psychopharmacology ( Berlin ). 187(1): 121-130, 2006.
  • Naghii MR, Wall PM, Samman S. The boron content of selected foods and the estimation of its daily intake among free-living subjects. J Am Coll Nutr. 1996 Dec;15(6):614-9. 
  • Neumeister, A., et al. Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy. Archives of General Psychiatry. 55: 524-530, 1998.
  • New SA et al. Nutritional influences on bone mineral density: a cross-sectional study in premenopausal women. Am J Clin Nutr. 65:1831-9, 1997.
  • Newnham RE. Essentiality of boron for healthy bones and joints. Environ Health Perspect. 1994;102:83-85 
  • Nielsen FH. Studies on the relationship between boron and magnesium which possibly affects the formation and maintenance of bones. Magnes Trace Elem. 1990;9:61-69 
  • Nielsen FH. Ultratrace minerals. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease, 9th ed. Baltimore, MD: Williams and Wilkins; 1999:283-303. 
  • Oginni LM, Sharp CA, Worsfold M, et al. Healing of rickets after calcium supplementation. Lancet. 1999; 353:296-297. 
  • Orchard TJ. Magnesium and type 2 diabetes mellitus (editorial). Arch Int Med. 1999; 159:2119-2120. 
  • Paolisso G et al. Daily magnesium supplements improve glucose handling in elderly subjects. Am J Clin Nutr. 55:1161-7, 1992.
  • Paolisso G, Sgamabato S, Pizza G, et al. Improved insulin response and action by chronic magnesium administration in aged NIDDM. Diabetes Care. 1989; 12:265-269. 
  • Peacock JM et al. Relationship of serum and dietary magnesium to incident hypertension: the Atherosclerosis Risk in Communities (ARIC) Study. Annals of Epidemiology. 9:159-65, 1999.
  • Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia. 1996; 16:257-263. 
  • Penland J.G. The importance of boron nutrition for brain and psychological function. Biol Trace Elem Res. 1998; 66:299-317.
  • Popoviciu L et al. Clinical, EEG, electromyographic and polysomnographic studies in restless legs syndrome caused by magnesium deficiency (abstract). Rom J Neurol Psychiatry. 31:55-61, 1993.
  • Preuss HG, Gondal JA, Lieberman S. Association of macronutrients and energy intake with hypertension. J Am Coll Nutr. 15:21-35, 1996.
  • Recker RR. Calcium absorption and achlorhydria. N Engl J Med. 1985; 313:70-73. 
  • Reid IR, Ames RW, Evans MC, et al. Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med. 1993; 328:460-464. 
  • Rivlin RS. Magnesium deficiency and alcohol intake: mechanisms, clinical significance and possible relation to cancer development (a review). J Am Coll Nutr. 1994; 13:416-423. 
  • Roberts JM. Magnesium for preeclampsia and eclampsia. N Engl J Med. 1995; 333:250-251. 
  • Rodriguez-Moran M and Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects. Diabetes Care. 26:1147-52, 2003.
  • Roffe C, Fletcher S, Woods KL. Investigation of the effects of intravenous magnesium sulphate on cardiac rhythm in acute myocardial infarction. Br Heart J. 1994; 71:141-145. 
  • Roffe, C., et al. Randomised, cross-over, placebo controlled trial of magnesium citrate in the treatment of chronic persistent leg cramps. Med Sci Monit. 8(5):CR326-CR330, 2002.
  • Rubinsztein, J., et al. Acute dietary tryptophan depletion impairs maintenance of “affective set” and delayed visual recognition in healthy volunteers. Psychopharmacology. 154: 319-326, 2001.
  • Rude KR. Magnesium metabolism and deficiency. Endocrinol Metab Clin North Am. 22:377-95, 1993.
  • Rude R et al. Magnesium deficiency and osteoporosis: animal and human observations. J Nutr Biochem. 15(12):710-716, 2004.
  • Russo, S, et al. Tryptophan as a link between psychopathology and somatic states. Psychosomatic Medicine. 65: 665-671, 2003.
  • Ryder K et al. Magnesium intake from food and supplements is associated with bone mineral density in healthy older white subjects. J Am Geriatr Soc. 53(11):1875-1880, 2005.
  • Sales CH et al. Influence of magnesium status and magnesium intake on the blood glucose control in patients with type 2 diabetes. Clin Nutr. 30(3):359-64, 2011.
  • Sanjuliani AF et al. Effects of magnesium on blood pressure and intracellular ion levels of Brazilian hypertensive patients. Int J Cardiol. 56:177-83, 1996.
  • Saris NE, Mervaala E, et al. Magnesium: an update on physiological, clinical, and analytical aspects. Clinica Chimica Acta. 294:1-26, 2000.
  • Saris N-EL, Mervaala E, Karppanen H, et al. Magnesium. An update on physiological, clinical and analytical aspects (review). Clinica Chimica Acta. 2000; 294:1-26. 
  • Saris, N.-E. L., et al. Magnesium: an update on physiological, clinical and analytical aspects. Clinica Chimica Acta. 294:1-26, 2000.
  • Sato-Mito N et al. The midpoint of sleep is associated with dietary intake and dietary behavior among young Japanese women. Sleep Med. 12(3):289-94, 2011.
  • Shechter M et al. Effects of oral magnesium therapy on exercise tolerance, exercise-induced chest pain, and quality of life in patients with coronary artery disease. Am J Cardiol. 91:517-21, 2003.
  • Shechter M et al. Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation.102:2353-58, 2000.
  • Shils ME. Magnesium. In: Shils M, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore, MD: Williams and Wilkins; 1999:169-192. 
  • Sinclair, S., et al. Migraine headaches: nutritional, botanical and other alternative approaches. Alternative Medicine Review. 4(2):86-95, 1999.
  • Singh MA. Combined exercise and dietary intervention to optimize body composition in aging. Ann N Y Acad Sci. 1998 Nov 20;854:378-93. 
  • Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of levothyroxine. JAMA. 2000; 283:2822-2825. 
  • Sojka JE. Magnesium supplementation and osteoporosis. Nutr Rev. 1995; 53:71-80. Strause L, Saltman P, Glowacki J. The effect of deficiencies of manganese and copper on osteo-induction and on resorption of bone particles in rats. Calcif Tissue Int. 1987; 41:145-150 
  • Song Y et al. Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women. Diabetes Care. 27:59-65, 2004.
  • South, J. L-Tryptophan, nature’s answer to Prozac®. International Antiaging Systems (IAS) Bulletin, 2007. (http://www.antiaginsystems.com/extract/ltrypt.htm)
  • Stendig-Lindberg G et al. Trabecular bone density in a two year controlled trial of peroral magnesium in osteoporosis. Magnes Res. 6:155-63, 1993.
  • Steritei, R. How to get a good night’s sleep with tryptophan. NaturDoctor. 2007. (www.naturdoctor.com/Chapters/Research/Insomnia.pdf)
  • Strause L, Saltman P, Smith KT, et al. Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals. J Nutr. 1994; 124:1060-1064. 
  • Sutherland B, Strong P, King JC. Determining human dietary requirements for boron. Biol Trace Elem Res. 1998 Winter;66(1-3):193-204. 
  • Svetkey LP et al. Effects of dietary patterns on blood pressure: Subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. Arch Intern Med. 159:285-93, 1999.
  • Talbot JR, Guardo P, Seccia S, et al. Calcium bioavailability and parathyroid hormone acute changes after oral intake of dairy and nondairy products in healthy volunteers. Osteoporosis Int. 1999; 10:137-142. 
  • Tanabe, K., et al. Efficacy of oral magnesium administration on decreased exercise tolerance in a state of chronic sleep deprivation. Jpn Circ J. 62(5):341-346, 1998.
  • Tanabe, K., et al. Erythrocyte magnesium and prostaglandin dynamics in chronic sleep deprivation. Clin Cardiol. 20(3):265-268, 1997.
  • Tobian L. Salt and hypertension. Lessons from animal models that relate to human hypertension. Hypertension. 1991; 17:152-158.
  • Tosiello L. Hypomagnesemia and diabetes mellitus. A review of clinical implications. Arch Intern Med. 1998; 156:1143-1148. 
  • Tranquilli AL et al. Calcium, phosphorus and magnesium intakes correlate with bone mineral content in postmenopausal women. Gynecol Endocrinol. 8:55-8, 1994.
  • Trauninger, A., et al. Oral magnesium load test in patients with migraine. Headache. 42(4):114-119, 2002.
  • Tucker KL, Hannan MT, Chen H, Cupples LA, Wilson PW, Kiel DP. Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women. Am J Clin Nutr. 69(4):727-36, 1999.
  • van der Veen, F., et al. Effects of acute tryptophan depletion on mood and facial emotion perception related brain activation and performance in healthy women with and without a family history of depression. Neuropsychopharmacology. 32: 216-224, 2007.
  • Voderholzer, U., et al. Impact of experimentally induced serotonin deficiency by tryptophan depletion on sleep EEG in healthy subjects. Neuropsychopharmacology 18(2): 112-124, 1998.
  • Volpe SL, Taper LJ, Meacham S. The relationship between boron and magnesium status and bone mineral density in the human: a review. Magnes Res. 1993;6:291-296 
  • Vormann J. Magnesium: nutrition and metabolism. Molecular Aspects of Medicine. 24:27-37, 2003.
  • Wang, F., et al. Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Headache. 43(6):601-610, 2003.
  • Wargovich MJ, Eng VWS, Newmark HL. Calcium inhibits the damaging and compensatory proliferative effects of fatty acids on mouse colon epithelium. Cancer Lett. 1984; 23:253-258. 
  • Weaver CM, Heaney RP. Calcium. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore, MD: Williams and Wilkins; 1999:141-155. 
  • Wester PO. Magnesium. Am J Clin Nutr. 45:1305-12, 1987.
  • Widman L et al. The dose-dependent reduction in blood pressure through administration of magnesium. A double blind placebo controlled cross-over study. Am J Hypertens. 6:41-5, 1993.
  • Wolf RL, Cauley JA, Baker CE, et al. Factors associated with calcium absorption efficiency in pre- and perimenopausal women. Am J Clin Nutr. 2000; 72:466-471. 
  • Woods KL, Fletcher S. Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet. 1994; 343:816-819. 
  • Woolhouse, M. Migraine and tension headache--a complementary and alternative medicine approach. Aust Fam Physician. 34(8):647-51, 2005. Review.
  • Yu-Yahiro, J. A. Electrolytes and their relationship to normal and abnormal muscle function. Orthop Nurs. 13(5):38-40, 1994.
  • Zemel MB, Shi H, Greer B, et al. Regulation of adiposity by dietary calcium. FASEB J. 2000; 14:1132-1138.

* 有關產品的陳述未經食品與藥物管理局評估。
此產品無意作為診斷、治療或預防疾病之用。

檢視

目前没有對此產品的評價。